Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Multicenter Prospective Evaluation of Diagnostic Potential of Flow Cytometric Aberrancies in Myelodysplastic Syndromes

Blood (2021) 138 (Supplement 1): 3995.

https://doi.org/10.1182/blood-2021-152298

Published: 2021

Journal Articles

WT-1 Expression Level In BM Is The Great Prognostic Marker In Three Of Classification IPSS, WPSS, and Latest Revised IPSS(IPSS-R)

Sumiko Kobayashi, MD, PhD, Yasunori Ueda, MD, PhD, Mineo Kurokawa, MD, PhD, Kiyoyuki Ogata, MD, PhD, Hirohiko Shibayama, Nobuhiko Emi, MD, PhD, Kensuke Usuki, MD, PhD, Kazuma Ohyashiki, MD, PhD, Keiya Ozawa, MD, PhD, Yasushi Miyazaki, MD, PhD, Akira Matsuda, MD, PhD, Kaoru Tohyama, MD, PhD, Kinuko Mitani, M.D., Ph.D., Tomoki Naoe, MD, PhD, Haruo Sugiyama, MD, PhD

Blood (2013) 122 (21): 2795.

https://doi.org/10.1182/blood.V122.21.2795.2795

Published: 2013

Journal Articles

CD7 Expression On Blasts Of Myelodysplastic Syndromes Is Associated With Apoptosis Resistance With Decreased Expression Of The Proapoptotic Protein Bad and An Independent Unfavorable Prognostic Factor Together With The Revised IPSS Score In Patients

Yasuko Hamada, MD, Hideto Tamura, MD, PhD, Mariko Ishibashi, PhD, Namiko Okuyama, MD, Asaka Kondo, MD, PhD, Keiichi Moriya, MD, PhD, Kiyoyuki Ogata, MD, PhD, Keiji Kakumoto, Yoshihide Miyazaki, Akira Matsuda, MD, PhD, Kaoru Tohyama, MD, PhD, Yasunori Ueda, MD, PhD, Mineo Kurokawa, MD, PhD, Hirohiko Shibayama, Nobuhiko Emi, MD, PhD, Kinuko Mitani, M.D., Ph.D., Tomoki Naoe, MD, PhD, Haruo Sugiyama, MD, PhD, Koiti Inokuchi, MD, PhD

Blood (2013) 122 (21): 2799.

https://doi.org/10.1182/blood.V122.21.2799.2799

Published: 2013

Journal Articles

B7-H1 Molecules on Myeloma Cells Induce Aggressive Cell Behavior

Hideto Tamura, MD, PhD, Mariko Ishibashi, PhD, Taishi Yamashita, PhD, Asaka Kondo, MD, PhD, Namiko Okuyama, MD, Hideya Hyodo, MD, PhD, Yasuko Hamada, MD, Kazuo Dan, MD, PhD, Lieping Chen, MD, PhD, Kiyoyuki Ogata

Blood (2011) 118 (21): 474.

https://doi.org/10.1182/blood.V118.21.474.474

Published: 2011

Journal Articles

Interferon-γ and tumor necrosis factor-α induce an immunoinhibitory molecule, B7-H1, via nuclear factor-κB activation in blasts in myelodysplastic syndromes

Asaka Kondo, Taishi Yamashita, Hideto Tamura, Wanhong Zhao, Takashi Tsuji, Masumi Shimizu, Eiji Shinya, Hidemi Takahashi, Koji Tamada, Lieping Chen, Kazuo Dan, Kiyoyuki Ogata

Blood (2010) 116 (7): 1124–1131.

https://doi.org/10.1182/blood-2009-12-255125

Published: 2010

Includes: Supplemental data

Journal Articles

Interferon-γ and Tumor Necrosis Factor-α Induce An Immunoinhibitory Molecule, B7-H1, Via NfκB Activation in Blasts of Myelodysplastic Syndromes.

Asaka Kondo, Hideto Tamura, Taishi Yamashita, Chikako Sato, Zhao Wanhong, Takashi Tsuji, Eiji Shinya, Hidemi Takahashi, Koji Tamada, Lieping Chen, Kazuo Dan, Kiyoyuki Ogata

Blood (2009) 114 (22): 2766.

https://doi.org/10.1182/blood.V114.22.2766.2766

Published: 2009

Journal Articles

Prognostic Significance of WT1 mRNA and Anti-WT1 Antibody Levels in Peripheral Blood in Patients with Myelodysplastic Syndromes.

Hideto Tamura, MD, PhD, Kazuo Dan, Norio Yokose, Rika Iwakiri, Masatsugu Ohta, Hisashi Sakamaki, Kaoru Tohyama, Kondo Asaka, Hideya Hyodo, Kyoko Nakamura, Taishi Yamashita, Olga A Elisseeva, Yoshihiro Oka, Yusuke Oji, Haruo Sugiyama, Kiyoyuki Ogata

Blood (2009) 114 (22): 3821.

https://doi.org/10.1182/blood.V114.22.3821.3821

Published: 2009

Journal Articles

Expression and Function of B7.2 and B7-H2 Molecules on Myeloma Cells

Taishi Yamashita, Hideto Tamura, MD, PhD, Chikako Sato, Asaka Kondo, Eiji Shinya, Hidemi Takahashi, Lieping Chen, Takashi Tsuji, Kazuo Dan, Kiyoyuki Ogata, MD, PhD

Blood (2008) 112 (11): 2722.

https://doi.org/10.1182/blood.V112.11.2722.2722

Published: 2008

Journal Articles

Diagnostic Utility of Flow Cytometry in Myelodysplastic Syndromes: A Prospective Validation Study in Low-Risk Patients with Normal Karyotype

Kiyoyuki Ogata, Matteo G. Della Porta, Luca Malcovati, Cristina Picone, Norio Yokose, Akira Matsuda, Taishi Yamashita, Hideto Tamura, Junichi Tsukada, Kazuo Dan, Mario Cazzola

Blood (2008) 112 (11): 3634.

https://doi.org/10.1182/blood.V112.11.3634.3634

Published: 2008

Journal Articles

Expression of WT-1 mRNA in Peripheral Blood from Myelodysplastic Syndromes

Hideto Tamura, MD, PhD, Kazuo Dan, Norio Yokose, Rika Iwakiri, Masatsugu Ohta, Hisashi Sakamaki, MD, PhD, Kaoru Tohyama, Asaka Kondo, Kyoko Nakamura, Taishi Yamashita, Takashi Tsuji, Kiyoyuki Ogata, MD, PhD

Blood (2008) 112 (11): 3637.

https://doi.org/10.1182/blood.V112.11.3637.3637

Published: 2008

Journal Articles

Expression of Functional B7-H1 Molecules on Blasts from Myelodysplastic Syndromes.

Asaka Kondo, MD, Taishi Yamashita, Hideto Tamura, MD, Chikako Sato, Risa Jo, Takashi Tsuji, PhD, Kazuo Dan, MD, Kiyoyuki Ogata, MD

Blood (2007) 110 (11): 2429.

https://doi.org/10.1182/blood.V110.11.2429.2429

Published: 2007

Journal Articles

B7.2 and B7-H2 Molecules Stimulate Proliferation of Myeloma Cells and Inhibit Anti-Myeloma Immune Responses.

Taishi Yamashita, Hideto Tamura, MD, Chikako Sato, Asaka Kondo, MD, Takashi Tsuji, PhD, Kazuo Dan, MD, Kiyoyuki Ogata, MD

Blood (2007) 110 (11): 3524.

https://doi.org/10.1182/blood.V110.11.3524.3524

Published: 2007

Journal Articles

Diagnostic application of flow cytometric characteristics of CD34 + cells in low-grade myelodysplastic syndromes

Kiyoyuki Ogata, Yoshifumi Kishikawa, Chikako Satoh, Hideto Tamura, Kazuo Dan, Akio Hayashi

Blood (2006) 108 (3): 1037–1044.

https://doi.org/10.1182/blood-2005-12-4916

Published: 2006

Includes: Supplemental data

Journal Articles

Flow Cytometric Characteristics of CD34+ Cells in Refractory Anemia: Their Diagnostic Value.

Kiyoyuki Ogata, MD, Yoshifumi Kishikawa, Tomoko Shimazaki, Chikako Satoh, MS, Hideto Tamura, MD, Yoshihiko Otsuka, Kazuo Dan, MD, Akio Hayashi, Mitsunobu Shimazu

Blood (2005) 106 (11): 4896.

https://doi.org/10.1182/blood.V106.11.4896.4896

Published: 2005

Journal Articles

Identification and Hematopoietic Potential of CD45-Negative Clonal Cells with Very Immature Phenotype (CD45 − CD34 − CD38 − Lin − ) in Patients with Myelodysplastic Syndromes.

Kiyoyuki Ogata, MD, PhD, Chikako Satoh, MS, Mikiko Tachibana, MD, Hideya Hyodo, MD, Hideto Tamura, MD, PhD, Kazuo Dan, MD, PhD, Takafumi Kimura, MD, Yoshiaki Sonoda, MD, PhD, Takashi Tsuji, PhD

Blood (2004) 104 (11): 3426.

https://doi.org/10.1182/blood.V104.11.3426.3426

Published: 2004

Journal Articles

Clinical significance of phenotypic features of blasts in patients with myelodysplastic syndrome

Kiyoyuki Ogata, Kyoko Nakamura, Norio Yokose, Hideto Tamura, Mikiko Tachibana, Osamu Taniguchi, Rika Iwakiri, Tatsuyuki Hayashi, Hisashi Sakamaki, Yoshiro Murai, Kaoru Tohyama, Shigeru Tomoyasu, Yasunobu Nonaka, Mayumi Mori, Kazuo Dan, Yataro Yoshida

Blood (2002) 100 (12): 3887–3896.

https://doi.org/10.1182/blood-2002-01-0222

Published: 2002

Journal Articles

Humoral immune responses against Wilms tumor gene WT1 product in patients with hematopoietic malignancies

Blood (2002) 99 (9): 3272–3279.

https://doi.org/10.1182/blood.V99.9.3272

Published: 2002

NARROW

Multicenter Prospective Evaluation of Diagnostic Potential of Flow Cytometric Aberrancies in Myelodysplastic Syndromes

WT-1 Expression Level In BM Is The Great Prognostic Marker In Three Of Classification IPSS, WPSS, and Latest Revised IPSS(IPSS-R)

CD7 Expression On Blasts Of Myelodysplastic Syndromes Is Associated With Apoptosis Resistance With Decreased Expression Of The Proapoptotic Protein Bad and An Independent Unfavorable Prognostic Factor Together With The Revised IPSS Score In Patients

B7-H1 Molecules on Myeloma Cells Induce Aggressive Cell Behavior

Interferon-γ and tumor necrosis factor-α induce an immunoinhibitory molecule, B7-H1, via nuclear factor-κB activation in blasts in myelodysplastic syndromes

Interferon-γ and Tumor Necrosis Factor-α Induce An Immunoinhibitory Molecule, B7-H1, Via NfκB Activation in Blasts of Myelodysplastic Syndromes.

Prognostic Significance of WT1 mRNA and Anti-WT1 Antibody Levels in Peripheral Blood in Patients with Myelodysplastic Syndromes.

Expression and Function of B7.2 and B7-H2 Molecules on Myeloma Cells

Diagnostic Utility of Flow Cytometry in Myelodysplastic Syndromes: A Prospective Validation Study in Low-Risk Patients with Normal Karyotype

Expression of WT-1 mRNA in Peripheral Blood from Myelodysplastic Syndromes

Expression of Functional B7-H1 Molecules on Blasts from Myelodysplastic Syndromes.

B7.2 and B7-H2 Molecules Stimulate Proliferation of Myeloma Cells and Inhibit Anti-Myeloma Immune Responses.

Diagnostic application of flow cytometric characteristics of CD34 + cells in low-grade myelodysplastic syndromes

Flow Cytometric Characteristics of CD34+ Cells in Refractory Anemia: Their Diagnostic Value.

Identification and Hematopoietic Potential of CD45-Negative Clonal Cells with Very Immature Phenotype (CD45 − CD34 − CD38 − Lin − ) in Patients with Myelodysplastic Syndromes.

Clinical significance of phenotypic features of blasts in patients with myelodysplastic syndrome

Humoral immune responses against Wilms tumor gene WT1 product in patients with hematopoietic malignancies

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only